Clinical trial
Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic…
NCT00003900 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003900 |
|---|---|
| Title | Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer |
| Official title | A Phase II Study of Irinotecan (CPT-11) and Docetaxel (Taxotere) in Patients With Recurrent Non-Small Cell Lung Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | docetaxel, irinotecan hydrochloride |
| Enrollment | 48 |
| Start date | Oct 1, 1999 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | May 3, 2004 |
| Last update posted | Jul 6, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: